vepafestinib
helsinn
['vepafestinib', ' rome']
exciting work by our group presented at #aacr23. and romel somwar. novel #ret inhibitor, vepafestinib, with activity against #cns mets and resistant solvent front and gatekeeper mutations! 
Medical Oncologist @NorthwellHealth Cancer Institute @LenoxHill